Companies: 10,795·Total market cap: $144.5T
MediPharm Labs Corp.

MediPharm Labs Corp.

LABS.TOTSXHealthcare● Active
$0.08
+$0.01(+7.14%)
Market Cap$31864801
P/E Ratio
52W High$0.1
52W Low$0.06

MediPharm Labs Corp. (LABS.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

LABS.TO · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$10.8M -7.6% vs prior year
FY · as of Dec 31, 2025 · Reported in CAD
Cash & Cash Equiv. (CCE)
$10.8M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-7.6%
vs prior fiscal year
Latest Quarter
$9.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$10.8MCash on Hand
Total Debt$201,000Total Debt
Net Cash / Net Debt+$10.6MNet Cash Position
Cash vs Debt Ratio
Cash 98%Debt 2%

MediPharm Labs Corp. has a net cash position of $10.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$10.8M$201,000 = +$10.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
LABS.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$10.8M-7.6%
Dec 31, 2024$11.7M-35.0%
Dec 31, 2023$18.0M-25.5%
Dec 31, 2022$24.1M-29.2%
Dec 31, 2021$34.1M+71.3%
LABS.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
MediPharm Labs Corp.
MediPharm Labs Corp.YOU
LABS.TO
$10.8M33.9%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

MediPharm Labs Corp. (LABS.TO) cash on hand as of December 31, 2025 is $10.8M, comprising $10.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as MediPharm Labs Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as MediPharm Labs Corp. cash reserves or cash position.

MediPharm Labs Corp. annual cash on hand history shows decreased -7.6% in 2025: decreased -7.6% in 2025. MediPharm Labs Corp. cash reserves in 2025 reflect the company's capital allocation strategy.

MediPharm Labs Corp. carries total debt of $201,000 against cash of $10.8M, resulting in a net cash position of +$10.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

LABS.TO cash on hand · 5 questions

As of December 31, 2025, MediPharm Labs Corp. (LABS.TO) has $10,806,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $10,806,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $9,866,000. Data sourced from the annual 10-K filing via FMP.

LABS.TO cash on handLABS.TO cash reservesLABS.TO cash 2025how much cash does LABS.TO have

Source: FMP /balance-sheet-statement · US GAAP · MediPharm Labs Corp. · MediPharm Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025